We found that hepatic TFEB overexpression significantly reduced WD-induced hepatic and gallbladder cholesterol accumulation and hypercholesterolemia (Fig. 8a–c), which correlated with significantly increased bile acid pool (Fig. 8d). The gene discussed is TFEB; the disease is Hypercholesterolemia.